Puma Biotechnology (PBYI) Shareholder's Equity Growth (1y) (2011 - 2026)
Puma Biotechnology (PBYI) Shareholder's Equity Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Puma Biotechnology |
384.39 Mn |
282.84 Mn |
34.39 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
32.24% |
| Dec 31, 2025 |
41.48% |
| Sep 30, 2025 |
62.15% |
| Jun 30, 2025 |
115.87% |
| Mar 31, 2025 |
90.48% |
| Dec 31, 2024 |
72.38% |
| Sep 30, 2024 |
83.49% |
| Jun 30, 2024 |
59.57% |
| Mar 31, 2024 |
97.25% |
| Dec 31, 2023 |
147.33% |
| Sep 30, 2023 |
74.87% |
| Jun 30, 2023 |
54.01% |
| Mar 31, 2023 |
261.75% |
| Dec 31, 2022 |
983.40% |
| Sep 30, 2022 |
302.85% |
| Jun 30, 2022 |
-33.02% |
| Mar 31, 2022 |
-56.26% |
| Dec 31, 2021 |
58.90% |
| Sep 30, 2021 |
-2,311.04% |
| Jun 30, 2021 |
25.92% |
